SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 70 filers reported holding SYROS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,000 | 0.0% | 1,590 | +218.0% | 0.00% | – |
| Q1 2022 | $1,000 | -98.9% | 500 | -98.1% | 0.00% | – |
| Q4 2021 | $87,000 | +314.3% | 26,659 | +455.4% | 0.00% | – |
| Q3 2021 | $21,000 | -71.2% | 4,800 | -64.2% | 0.00% | – |
| Q2 2021 | $73,000 | +192.0% | 13,417 | +299.0% | 0.00% | – |
| Q1 2021 | $25,000 | -82.1% | 3,363 | -73.9% | 0.00% | – |
| Q4 2020 | $140,000 | +154.5% | 12,900 | +108.1% | 0.00% | – |
| Q3 2020 | $55,000 | -60.4% | 6,200 | -52.3% | 0.00% | – |
| Q2 2020 | $139,000 | +40.4% | 13,009 | -22.3% | 0.00% | – |
| Q1 2020 | $99,000 | -67.8% | 16,742 | -62.4% | 0.00% | – |
| Q4 2019 | $307,000 | +30.6% | 44,488 | +96.5% | 0.00% | – |
| Q3 2019 | $235,000 | +343.4% | 22,643 | +290.5% | 0.00% | – |
| Q2 2019 | $53,000 | +15.2% | 5,798 | +15.8% | 0.00% | – |
| Q1 2019 | $46,000 | +228.6% | 5,007 | +95.6% | 0.00% | – |
| Q4 2018 | $14,000 | -90.3% | 2,560 | -78.7% | 0.00% | – |
| Q3 2018 | $144,000 | +108.7% | 12,038 | +78.2% | 0.00% | – |
| Q2 2018 | $69,000 | +6.2% | 6,754 | +33.9% | 0.00% | – |
| Q1 2018 | $65,000 | +12.1% | 5,044 | -14.7% | 0.00% | – |
| Q4 2017 | $58,000 | +262.5% | 5,914 | +439.1% | 0.00% | – |
| Q3 2017 | $16,000 | +23.1% | 1,097 | +35.9% | 0.00% | – |
| Q2 2017 | $13,000 | +8.3% | 807 | +3.6% | 0.00% | – |
| Q1 2017 | $12,000 | 0.0% | 779 | -19.3% | 0.00% | – |
| Q4 2016 | $12,000 | – | 965 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 3,139,895 | $23,486,000 | 4.50% |
| Samsara BioCapital, LLC | 2,189,199 | $14,769,000 | 2.72% |
| Bain Capital Life Sciences Investors, LLC | 5,785,036 | $43,272,000 | 2.45% |
| Omega Fund Management, LLC | 1,562,500 | $11,688,000 | 1.11% |
| Flagship Pioneering Inc. | 2,938,494 | $21,980,000 | 0.35% |
| EcoR1 Capital, LLC | 1,000,000 | $7,480,000 | 0.33% |
| Altium Capital Management LP | 126,702 | $948,000 | 0.26% |
| Nikko Asset Management Americas, Inc. | 5,042,009 | $37,714,000 | 0.18% |
| Artal Group S.A. | 1,025,000 | $7,667,000 | 0.14% |
| Orbimed Advisors | 1,837,500 | $13,745,000 | 0.13% |